Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease. - Wikidata - wikimedia - TriplyDB

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

http://www.wikidata.org/entity/Q30484944

about

Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease Sympathetic nervous system overactivity and its role in the development of cardiovascular disease Mindfulness meditation lowers muscle sympathetic nerve activity and blood pressure in African-American males with chronic kidney disease Chronic heart failure does not attenuate the total activity of sympathetic outflow to skin during whole-body heating Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis.Human sympathetic outflows to skin and muscle target organs fluctuate concordantly over a wide range of time-varying frequencies.Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep.Tetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.Abnormal neurocirculatory control during exercise in humans with chronic renal failure.Mental Stress Elicits Sustained and Reproducible Increases in Skin Sympathetic Nerve Activity Tetrahydrobiopterin ameliorates the exaggerated exercise pressor response in patients with chronic kidney disease: a randomized controlled trial Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease.Specific control of sympathetic nerve activity to the mammalian heart and kidney.Renal denervation and hypertension.Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function.Measuring and quantifying skin sympathetic nervous system activity in humans.Prognostic indicators of cardiovascular risk in renal disease.Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system.Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.

P2860

Q24617193-E15BE4C0-3974-42B9-A0B7-9C782ADF9B32 Q28279754-EFDBFB59-7460-4378-A0EE-BE4F5B8003A7 Q30384352-6C1CA47C-CE24-4558-81CE-521E3FF2EA8B Q30542466-11354EBD-9EE9-43C7-B911-1325871DC44E Q33695671-88BCDCBC-67C2-43C5-8013-D6D8A1F5EEFE Q34069255-86AF7B25-D7F4-4C1C-B6D5-3D7316515030 Q34308212-96399659-7BD1-4637-8338-09E0B4931ED7 Q35035498-EE966FFD-72F8-4C21-9CF6-D96C7595B49B Q35107987-81009A99-AA94-45DF-866E-ACE578B1D945 Q36905486-69EC3741-D46D-42B6-B00E-9AF66B7391F6 Q37211804-94C2EA91-C9E4-42FE-9DFF-929841814208 Q37285513-80E99936-CC21-4591-B81D-F27A8C33657F Q37555769-46CEAF3E-1EAF-48E1-8AE3-6BCF279C13B0 Q37851825-00F0E640-5466-4B99-946E-25F03393E736 Q38208753-235ADCF4-C497-4D9C-B22D-80AB64A2B82E Q38527010-25FFF736-DE65-4F8F-A11F-0226C2E0F8DB Q38720541-8CA52229-74CE-4267-82C6-F80702142832 Q39431331-BC988F03-059F-42C6-BDBA-3F0D55A530E7 Q40389486-B7BCCD66-95D3-4912-8DCE-2B409E220C32 Q41573480-0A895B02-9A5D-42F5-90F5-FAD1EA1FA643 Q41838379-0A4951AF-4EA3-4963-AFE9-96E6164B3919 Q47950986-2AE08A5E-DBA4-4D06-A4A1-D3F556FA2517

P2860

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

http://www.wikidata.org/entity/Q30484944

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Differential distribution of m ...... with end-stage renal disease.

@ast

Differential distribution of m ...... with end-stage renal disease.

@en

type

label

Differential distribution of m ...... with end-stage renal disease.

@ast

Differential distribution of m ...... with end-stage renal disease.

@en

prefLabel

Differential distribution of m ...... with end-stage renal disease.

@ast

Differential distribution of m ...... with end-stage renal disease.

@en

P1433

Q30484944-1C3267D7-3CFF-401A-9BE7-B668D7C5ABE3

P1476

Q30484944-EB598831-E135-47CB-B381-0466DF168645

P2093

Q30484944-68FEE327-8786-4E19-B39A-36AE9FA5639A

Q30484944-E10DA37D-487E-4EA1-8107-412D564F5C52

Q30484944-FEC00268-904D-4695-AA1B-61F15F3CBB14

P2860

Q30484944-0749BCB7-36E3-47B8-B7D9-8B3DDD013AA3

Q30484944-0D2FE082-E0AC-44E9-AD7D-63FD3B28EE9C

Q30484944-25521F8A-2409-42CC-BEA0-A4766674BB6E

Q30484944-27DF64C6-29C1-4616-836D-5AFCDBA7E16C

Q30484944-2DF3F345-3E09-471D-9918-14BA4F799BE9

Q30484944-2E91AED7-9A70-4E07-B6C7-52FAA39DD628

Q30484944-3E029936-716C-41E9-86A0-765905CD1068

Q30484944-45E817C0-32A9-49CD-81B7-76AC620F2F7E

Q30484944-47472ED7-5DE0-4288-89AB-435C177930B7

Q30484944-4F9DE934-4044-4905-8383-A7295475D82A

P304

Q30484944-F168E397-B8BB-41E4-8152-414DC2F9127E

P31

Q30484944-5425149A-9FBA-4752-A659-A4C9AF285E23

P356

Q30484944-D7AA90BA-6602-431E-A01C-3ACF79F23E88

P407

Q30484944-24A64117-CDB0-4025-A01B-65F49CCC52B6

P433

Q30484944-7869D8CE-5722-47F5-ADED-EEF84A85AEBE

P478

Q30484944-99C5F587-58F3-4D52-B824-C27F57F0A295

P50

Q30484944-475199A0-0733-433B-BA23-A3343B6CD182

P577

Q30484944-204F38C2-8D4B-4585-B777-1351D3C99C6E

P5875

Q30484944-759658E1-40E2-450D-985D-3BF5881E3EEB

P698

Q30484944-5FFB9E7F-A7B2-4D57-8625-A42EF1903873

P932

Q30484944-E1EDC3FF-D5C1-49CD-8EF6-97E832848F2E

P356

JAPPLPHYSIOL.90849.2008

P1433

Journal of Applied Physiology

P1476

Differential distribution of m ...... s with end-stage renal disease

@en

P2093

Holly R Middlekauff

http://www.w3.org/2001/XMLSchema#string

Niloofar Nobakht

http://www.w3.org/2001/XMLSchema#string

Vito M Campese

http://www.w3.org/2001/XMLSchema#string

P2860

Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humans

Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension.

Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system.

Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.

Plasma leptin is partly cleared by the kidney and is elevated in hemodialysis patients.

Peripheral sympathetic neural activity in conscious humans.

Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog.

Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide.

Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.

Manoeuvres affecting sympathetic outflow in human skin nerves.

P304

1873-1876

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/JAPPLPHYSIOL.90849.2008

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23310088

http://www.w3.org/2001/XMLSchema#string

P698

18845779

http://www.w3.org/2001/XMLSchema#string

P932

2612470

http://www.w3.org/2001/XMLSchema#string